Found: 467
Select item for more details and to access through your institution.
Shortages of Essential Generic Drugs with Limited Competition.
- Published in:
- 2024
- By:
- Publication type:
- Letter
The most transformative drugs of the past 25 years: a survey of physicians.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 425, doi. 10.1038/nrd3977
- By:
- Publication type:
- Article
Life Cycle of Medical Product Rules Issued by the US Food and Drug Administration.
- Published in:
- Journal of Health Politics, Policy & Law, 2014, v. 39, n. 4, p. 751, doi. 10.1215/03616878-2743027
- By:
- Publication type:
- Article
Incentivizing Antibiotic Development: Why Isn't the Generating Antibiotic Incentives Now (GAIN) Act Working?
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1093/ofid/ofaa001
- By:
- Publication type:
- Article
Regulatory Solutions to the Problem of High Generic Drug Costs.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 4, p. 1, doi. 10.1093/ofid/ofv179
- By:
- Publication type:
- Article
Competition law and pricing among biologic drugs: the case of VEGF therapy for retinal diseases.
- Published in:
- Journal of Law & the Biosciences, 2022, v. 9, n. 1, p. 1, doi. 10.1093/jlb/lsac001
- By:
- Publication type:
- Article
Patent Portfolios Protecting 10 Top-Selling Prescription Drugs.
- Published in:
- JAMA Internal Medicine, 2024, v. 184, n. 7, p. 810, doi. 10.1001/jamainternmed.2024.0836
- By:
- Publication type:
- Article
Cost of Exempting Sole Orphan Drugs From Medicare Negotiation.
- Published in:
- JAMA Internal Medicine, 2024, v. 184, n. 1, p. 63, doi. 10.1001/jamainternmed.2023.6293
- By:
- Publication type:
- Article
Why Some Patients Overpay for Specialty Generic Drugs.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
Authority of Medicare to Limit Coverage of FDA-Approved Products: Legal and Policy Considerations.
- Published in:
- JAMA Internal Medicine, 2023, v. 183, n. 9, p. 999, doi. 10.1001/jamainternmed.2023.3961
- By:
- Publication type:
- Article
Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers.
- Published in:
- JAMA Internal Medicine, 2023, v. 183, n. 7, p. 685, doi. 10.1001/jamainternmed.2023.1245
- By:
- Publication type:
- Article
Estimated Medicaid Spending on Original and Citrate-Free Adalimumab From 2014 Through 2021.
- Published in:
- JAMA Internal Medicine, 2023, v. 183, n. 3, p. 275, doi. 10.1001/jamainternmed.2022.6299
- By:
- Publication type:
- Article
Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare Savings.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Holding Pharmaceutical and Medical Device Executives Accountable as Responsible Corporate Officers.
- Published in:
- 2022
- By:
- Publication type:
- journal article
What to Know About the Alzheimer Drug Aducanumab (Aduhelm).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Extending Drug Monopolies by Patenting Safe Drug Use.
- Published in:
- 2022
- By:
- Publication type:
- journal article
New Treatments for Migraine-Therapeutic Ratings and Comparative Coverage in the US, Canada, and Europe.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Medicaid Spending on Drugs Marketed Without US Food and Drug Administration Approval in 2020.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Payer-Specific Negotiated Prices for Prescription Drugs at Top-Performing US Hospitals.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Public-sector Contributions to Novel Biologic Drugs.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Fulfilling the Mandate of the US Food and Drug Administration's Accelerated Approval Pathway: The Need for Reforms.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Will Ending the Medicaid Drug Rebate Cap Lower Drug Prices?
- Published in:
- 2021
- By:
- Publication type:
- journal article
Market Exclusivity and Changes in Competition and Prices Associated With the US Food and Drug Administration Unapproved Drug Initiative.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Integrating New Effectiveness Data Into US Food and Drug Administration-Approved Drug Labeling.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Frequency of First Generic Drug Approvals With "Skinny Labels" in the United States.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Substitution of Generic Drugs and Biosimilars-Reply.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Internet Searches for Unproven COVID-19 Therapies in the United States.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Estimation of Medicare Part D Spending on Insulin for Patients With Diabetes Using Negotiated Prices and a Defined Formulary.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Potential Medicare Savings on Inhaler Prescriptions Through the Use of Negotiated Prices and a Defined Formulary.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Confidentiality Orders and Public Interest in Drug and Medical Device Litigation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
US Food and Drug Administration Recommendations on the Use of Surrogate Measures as End Points in New Anti-infective Drug Approvals.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Potential Medicare Savings From Generic Substitution and Therapeutic Interchange of ACE Inhibitors and Angiotensin-II-Receptor Blockers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Tepid Steps on Drug Pricing.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Assessment of Use of Combined Dextromethorphan and Quinidine in Patients With Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar Affect.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Labeling Changes and Costs for Clinical Trials Performed Under the US Food and Drug Administration Pediatric Exclusivity Extension, 2007 to 2012.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Shortage of Normal Saline in the Wake of Hurricane Maria.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Delayed Generic Market Saturation After Patent Expiration-A Billion-Dollar Problem.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Use of Health Care Databases to Support Supplemental Indications of Approved Medications.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Strategies That Delay Market Entry of Generic Drugs.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Determinants of Market Exclusivity for Prescription Drugs in the United States.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Medicaid Expenditures and Estimated Rebates for Epinephrine Autoinjectors, 2012 to 2016.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prioritization of Generic Drug Review-Reply.
- Published in:
- 2017
- By:
- Publication type:
- journal article